Article
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens.
Clinical pharmacology and therapeutics - 1 Apr 2021
Nicoletti Paola, Devarbhavi Harshad, Goel Ashish, Venkatesan Radha, Eapen Chundamannil E, Grove Jane I, Zafer Samreen, Bjornsson Einar, Lucena M Isabel, Andrade Raul J, Pirmohamed Munir, Wadelius Mia, Larrey Dominique, Maitland-van der Zee Anke-Hilse, Ibanez Luisa, Watkins Paul B, Daly Ann K, Aithal Guruprasad P
Abstract excerpt
Drug-induced liver injury (DILI) is a complication of treatment with antituberculosis (TB) drugs, especially in isoniazid (INH)-containing regimens. To investigate genetic risk factors, we performed a genomewide association study (GWAS) involving anti-TB DILI cases (55 Indian and 70 European) and controls (1,199 Indian and 10,397 European). Most cases were treated with a standard anti-TB drug regimen; all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
